Calcium in PDB 3wv3: Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide
Protein crystallography data
The structure of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide, PDB code: 3wv3
was solved by
H.Oki,
Y.Tanaka,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.83 /
1.60
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.558,
36.352,
95.853,
90.00,
130.64,
90.00
|
R / Rfree (%)
|
16.3 /
21.2
|
Other elements in 3wv3:
The structure of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide
(pdb code 3wv3). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide, PDB code: 3wv3:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 3wv3
Go back to
Calcium Binding Sites List in 3wv3
Calcium binding site 1 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:14.2
occ:1.00
|
OE2
|
A:GLU205
|
2.2
|
20.1
|
1.0
|
O
|
A:GLY180
|
2.3
|
15.5
|
1.0
|
OD2
|
A:ASP202
|
2.3
|
13.0
|
1.0
|
OD1
|
A:ASP179
|
2.3
|
15.2
|
1.0
|
O
|
A:SER182
|
2.3
|
19.0
|
1.0
|
O
|
A:LEU184
|
2.3
|
14.9
|
1.0
|
CG
|
A:ASP202
|
3.4
|
11.9
|
1.0
|
C
|
A:SER182
|
3.5
|
23.0
|
1.0
|
CG
|
A:ASP179
|
3.5
|
20.6
|
1.0
|
CD
|
A:GLU205
|
3.5
|
20.3
|
1.0
|
C
|
A:GLY180
|
3.5
|
16.0
|
1.0
|
C
|
A:LEU184
|
3.5
|
15.7
|
1.0
|
N
|
A:SER182
|
3.9
|
21.9
|
1.0
|
N
|
A:LEU184
|
3.9
|
17.1
|
1.0
|
C
|
A:PRO181
|
4.0
|
21.6
|
1.0
|
OD2
|
A:ASP179
|
4.0
|
20.9
|
1.0
|
N
|
A:GLY180
|
4.2
|
15.7
|
1.0
|
CA
|
A:LEU184
|
4.2
|
16.3
|
1.0
|
C
|
A:GLY183
|
4.2
|
19.0
|
1.0
|
CB
|
A:ASP202
|
4.2
|
11.0
|
1.0
|
CA
|
A:SER182
|
4.2
|
24.3
|
1.0
|
CG
|
A:GLU205
|
4.3
|
14.7
|
1.0
|
OD1
|
A:ASP202
|
4.3
|
11.1
|
1.0
|
C
|
A:ASP179
|
4.3
|
16.4
|
1.0
|
N
|
A:ASP179
|
4.3
|
15.4
|
1.0
|
CA
|
A:PRO181
|
4.4
|
20.0
|
1.0
|
OE1
|
A:GLU205
|
4.4
|
18.8
|
1.0
|
N
|
A:PRO181
|
4.4
|
18.9
|
1.0
|
O
|
A:PRO181
|
4.4
|
23.5
|
1.0
|
N
|
A:GLY183
|
4.4
|
19.9
|
1.0
|
CA
|
A:GLY180
|
4.4
|
15.8
|
1.0
|
CA
|
A:GLY183
|
4.5
|
18.9
|
1.0
|
CB
|
A:LEU184
|
4.6
|
20.0
|
1.0
|
N
|
A:LEU185
|
4.6
|
13.9
|
1.0
|
CA
|
A:ASP179
|
4.6
|
17.4
|
1.0
|
CB
|
A:ASP179
|
4.6
|
17.6
|
1.0
|
O
|
A:ASP179
|
4.7
|
16.2
|
1.0
|
O
|
A:GLY183
|
4.7
|
19.1
|
1.0
|
O
|
A:HOH539
|
4.9
|
32.5
|
1.0
|
CA
|
A:LEU185
|
4.9
|
14.7
|
1.0
|
|
Calcium binding site 2 out
of 4 in 3wv3
Go back to
Calcium Binding Sites List in 3wv3
Calcium binding site 2 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:16.1
occ:1.00
|
O
|
A:GLY196
|
2.3
|
15.0
|
1.0
|
O
|
A:ASN194
|
2.3
|
21.6
|
1.0
|
O
|
A:HOH409
|
2.3
|
15.6
|
1.0
|
O
|
A:ASP162
|
2.4
|
15.2
|
1.0
|
O
|
A:HOH416
|
2.4
|
15.1
|
1.0
|
OD1
|
A:ASP198
|
2.4
|
12.0
|
1.0
|
CG
|
A:ASP198
|
3.4
|
16.3
|
1.0
|
C
|
A:GLY196
|
3.5
|
15.1
|
1.0
|
C
|
A:ASP162
|
3.5
|
12.4
|
1.0
|
C
|
A:ASN194
|
3.6
|
20.4
|
1.0
|
C
|
A:TYR195
|
3.9
|
16.7
|
1.0
|
OD2
|
A:ASP198
|
3.9
|
17.1
|
1.0
|
N
|
A:GLY196
|
3.9
|
17.1
|
1.0
|
O
|
A:TYR195
|
4.1
|
14.9
|
1.0
|
O
|
A:ALA161
|
4.2
|
14.9
|
1.0
|
N
|
A:ASP198
|
4.2
|
11.8
|
1.0
|
O
|
A:HOH589
|
4.2
|
50.1
|
1.0
|
CA
|
A:GLY196
|
4.2
|
14.4
|
1.0
|
O
|
A:HOH474
|
4.3
|
22.3
|
1.0
|
CA
|
A:ASP162
|
4.3
|
13.9
|
1.0
|
CA
|
A:TYR195
|
4.3
|
19.5
|
1.0
|
N
|
A:TYR195
|
4.4
|
20.3
|
1.0
|
O
|
A:GLY192
|
4.4
|
18.5
|
1.0
|
N
|
A:GLY197
|
4.5
|
13.6
|
1.0
|
CA
|
A:ASN194
|
4.5
|
23.2
|
1.0
|
N
|
A:ILE163
|
4.5
|
11.3
|
1.0
|
N
|
A:ASN194
|
4.6
|
23.1
|
1.0
|
CB
|
A:ASP198
|
4.6
|
13.1
|
1.0
|
CA
|
A:GLY197
|
4.6
|
13.0
|
1.0
|
C
|
A:GLY197
|
4.7
|
12.8
|
1.0
|
O
|
A:HOH427
|
4.7
|
17.5
|
1.0
|
N
|
A:MET164
|
4.7
|
12.4
|
1.0
|
CA
|
A:ILE163
|
4.7
|
11.4
|
1.0
|
CA
|
A:ASP198
|
4.8
|
12.6
|
1.0
|
CG
|
A:MET164
|
4.8
|
14.3
|
1.0
|
C
|
A:PRO193
|
4.8
|
21.7
|
1.0
|
CH2
|
A:TRP113
|
4.9
|
20.1
|
1.0
|
|
Calcium binding site 3 out
of 4 in 3wv3
Go back to
Calcium Binding Sites List in 3wv3
Calcium binding site 3 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca303
b:18.8
occ:1.00
|
OE2
|
B:GLU205
|
2.2
|
23.3
|
1.0
|
O
|
B:GLY180
|
2.2
|
21.9
|
1.0
|
O
|
B:LEU184
|
2.3
|
18.2
|
1.0
|
OD2
|
B:ASP202
|
2.3
|
15.7
|
1.0
|
O
|
B:SER182
|
2.3
|
24.8
|
1.0
|
OD1
|
B:ASP179
|
2.4
|
20.3
|
1.0
|
CG
|
B:ASP202
|
3.4
|
17.1
|
1.0
|
C
|
B:LEU184
|
3.4
|
17.5
|
1.0
|
CD
|
B:GLU205
|
3.5
|
19.1
|
1.0
|
C
|
B:GLY180
|
3.5
|
21.9
|
1.0
|
C
|
B:SER182
|
3.5
|
26.7
|
1.0
|
CG
|
B:ASP179
|
3.6
|
21.7
|
1.0
|
N
|
B:LEU184
|
3.9
|
20.8
|
1.0
|
N
|
B:SER182
|
3.9
|
27.2
|
1.0
|
C
|
B:PRO181
|
4.0
|
26.4
|
1.0
|
N
|
B:GLY180
|
4.1
|
22.0
|
1.0
|
CB
|
B:ASP202
|
4.1
|
16.0
|
1.0
|
OD2
|
B:ASP179
|
4.1
|
24.2
|
1.0
|
CA
|
B:LEU184
|
4.2
|
19.3
|
1.0
|
CA
|
B:SER182
|
4.2
|
27.8
|
1.0
|
C
|
B:GLY183
|
4.3
|
21.8
|
1.0
|
OE1
|
B:GLU205
|
4.3
|
21.0
|
1.0
|
N
|
B:ASP179
|
4.3
|
21.9
|
1.0
|
C
|
B:ASP179
|
4.3
|
22.7
|
1.0
|
OD1
|
B:ASP202
|
4.3
|
15.3
|
1.0
|
CA
|
B:GLY180
|
4.4
|
22.1
|
1.0
|
CG
|
B:GLU205
|
4.4
|
22.4
|
1.0
|
N
|
B:PRO181
|
4.4
|
23.8
|
1.0
|
O
|
B:PRO181
|
4.4
|
26.9
|
1.0
|
CA
|
B:PRO181
|
4.4
|
25.2
|
1.0
|
N
|
B:LEU185
|
4.5
|
17.7
|
1.0
|
N
|
B:GLY183
|
4.5
|
23.4
|
1.0
|
CB
|
B:LEU184
|
4.5
|
17.9
|
1.0
|
CA
|
B:ASP179
|
4.6
|
22.5
|
1.0
|
CA
|
B:GLY183
|
4.7
|
22.7
|
1.0
|
CB
|
B:ASP179
|
4.7
|
22.8
|
1.0
|
CA
|
B:LEU185
|
4.7
|
17.2
|
1.0
|
O
|
B:GLY183
|
4.8
|
23.3
|
1.0
|
O
|
B:ASP179
|
4.8
|
23.6
|
1.0
|
|
Calcium binding site 4 out
of 4 in 3wv3
Go back to
Calcium Binding Sites List in 3wv3
Calcium binding site 4 out
of 4 in the Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of the Catalytic Domain of Mmp-13 Complexed with N- (3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2- Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca304
b:15.9
occ:1.00
|
O
|
B:GLY196
|
2.3
|
17.2
|
1.0
|
O
|
B:ASN194
|
2.3
|
18.8
|
1.0
|
O
|
B:ASP162
|
2.3
|
14.7
|
1.0
|
O
|
B:HOH423
|
2.4
|
16.8
|
1.0
|
O
|
B:HOH449
|
2.4
|
20.2
|
1.0
|
OD1
|
B:ASP198
|
2.4
|
16.3
|
1.0
|
CG
|
B:ASP198
|
3.4
|
16.2
|
1.0
|
C
|
B:GLY196
|
3.5
|
14.2
|
1.0
|
C
|
B:ASP162
|
3.5
|
13.3
|
1.0
|
C
|
B:ASN194
|
3.5
|
21.2
|
1.0
|
C
|
B:TYR195
|
3.9
|
17.0
|
1.0
|
OD2
|
B:ASP198
|
3.9
|
17.6
|
1.0
|
N
|
B:GLY196
|
4.0
|
17.1
|
1.0
|
O
|
B:TYR195
|
4.0
|
18.1
|
1.0
|
O
|
B:ALA161
|
4.1
|
16.8
|
1.0
|
O
|
B:HOH500
|
4.1
|
23.8
|
1.0
|
N
|
B:ASP198
|
4.1
|
14.9
|
1.0
|
CA
|
B:ASP162
|
4.2
|
14.2
|
1.0
|
O
|
B:HOH498
|
4.3
|
45.8
|
1.0
|
CA
|
B:GLY196
|
4.3
|
15.9
|
1.0
|
N
|
B:TYR195
|
4.4
|
18.4
|
1.0
|
CA
|
B:TYR195
|
4.4
|
18.5
|
1.0
|
N
|
B:ASN194
|
4.4
|
22.5
|
1.0
|
CA
|
B:ASN194
|
4.4
|
23.2
|
1.0
|
O
|
B:GLY192
|
4.4
|
20.6
|
1.0
|
N
|
B:GLY197
|
4.4
|
15.2
|
1.0
|
N
|
B:ILE163
|
4.5
|
12.5
|
1.0
|
CA
|
B:GLY197
|
4.6
|
13.5
|
1.0
|
CB
|
B:ASP198
|
4.6
|
14.4
|
1.0
|
C
|
B:GLY197
|
4.6
|
15.4
|
1.0
|
N
|
B:MET164
|
4.7
|
11.9
|
1.0
|
CA
|
B:ILE163
|
4.7
|
14.1
|
1.0
|
CA
|
B:ASP198
|
4.7
|
13.6
|
1.0
|
O
|
B:HOH439
|
4.7
|
18.1
|
1.0
|
C
|
B:PRO193
|
4.8
|
23.3
|
1.0
|
CG
|
B:MET164
|
4.9
|
14.0
|
1.0
|
O
|
B:PRO193
|
5.0
|
23.4
|
1.0
|
CH2
|
B:TRP113
|
5.0
|
17.8
|
1.0
|
|
Reference:
H.Nara,
K.Sato,
T.Naito,
H.Mototani,
H.Oki,
Y.Yamamoto,
H.Kuno,
T.Santou,
N.Kanzaki,
J.Terauchi,
O.Uchikawa,
M.Kori.
Thieno[2,3-D]Pyrimidine-2-Carboxamides Bearing A Carboxybenzene Group at 5-Position: Highly Potent, Selective, and Orally Available Mmp-13 Inhibitors Interacting with the S1 Binding Site Bioorg.Med.Chem. 2014.
ISSN: ESSN 1464-3391
PubMed: 25192810
DOI: 10.1016/J.BMC.2014.07.025
Page generated: Sat Jul 13 21:26:02 2024
|